BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38092886)

  • 21. Microbiome: Gut microbiota sways response to cancer immunotherapy.
    York A
    Nat Rev Microbiol; 2018 Mar; 16(3):121. PubMed ID: 29355853
    [No Abstract]   [Full Text] [Related]  

  • 22. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota.
    Dong M; Meng Z; Kuerban K; Qi F; Liu J; Wei Y; Wang Q; Jiang S; Feng M; Ye L
    Cell Death Dis; 2018 Oct; 9(10):1039. PubMed ID: 30305604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy.
    Olekhnovich EI; Ivanov AB; Babkina AA; Sokolov AA; Ulyantsev VI; Fedorov DE; Ilina EN
    mSystems; 2023 Apr; 8(2):e0102322. PubMed ID: 36809182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross communication of diet-microbiome-immune interactions in cancer immunotherapy.
    Zhou CB; Fang JY
    Cell Rep Med; 2022 Nov; 3(11):100806. PubMed ID: 36384089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial.
    Borgers JSW; Burgers FH; Terveer EM; van Leerdam ME; Korse CM; Kessels R; Flohil CC; Blank CU; Schumacher TN; van Dijk M; Henderickx JGE; Keller JJ; Verspaget HW; Kuijper EJ; Haanen JBAG
    BMC Cancer; 2022 Dec; 22(1):1366. PubMed ID: 36585700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intestinal microbiota affects immunotherapy in melanoma patients].
    Schmutz JL
    Ann Dermatol Venereol; 2016 Oct; 143(10):669-670. PubMed ID: 27546223
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination Immunotherapy Development in Melanoma.
    Eggermont AMM; Crittenden M; Wargo J
    Am Soc Clin Oncol Educ Book; 2018 May; 38():197-207. PubMed ID: 30231333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota.
    Bouferraa Y; Fares C; Bou Zerdan M; Boyce Kennedy L
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microbiome: a basis for novel immunomodulation in mice and men.
    Zarour HM
    Clin Adv Hematol Oncol; 2017 Jul; 15(7):535-536. PubMed ID: 28749917
    [No Abstract]   [Full Text] [Related]  

  • 30. Microbiome transplant-induced response to immunotherapy.
    Stower H
    Nat Med; 2021 Jan; 27(1):21. PubMed ID: 33442010
    [No Abstract]   [Full Text] [Related]  

  • 31. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
    Spencer CN; McQuade JL; Gopalakrishnan V; McCulloch JA; Vetizou M; Cogdill AP; Khan MAW; Zhang X; White MG; Peterson CB; Wong MC; Morad G; Rodgers T; Badger JH; Helmink BA; Andrews MC; Rodrigues RR; Morgun A; Kim YS; Roszik J; Hoffman KL; Zheng J; Zhou Y; Medik YB; Kahn LM; Johnson S; Hudgens CW; Wani K; Gaudreau PO; Harris AL; Jamal MA; Baruch EN; Perez-Guijarro E; Day CP; Merlino G; Pazdrak B; Lochmann BS; Szczepaniak-Sloane RA; Arora R; Anderson J; Zobniw CM; Posada E; Sirmans E; Simon J; Haydu LE; Burton EM; Wang L; Dang M; Clise-Dwyer K; Schneider S; Chapman T; Anang NAS; Duncan S; Toker J; Malke JC; Glitza IC; Amaria RN; Tawbi HA; Diab A; Wong MK; Patel SP; Woodman SE; Davies MA; Ross MI; Gershenwald JE; Lee JE; Hwu P; Jensen V; Samuels Y; Straussman R; Ajami NJ; Nelson KC; Nezi L; Petrosino JF; Futreal PA; Lazar AJ; Hu J; Jenq RR; Tetzlaff MT; Yan Y; Garrett WS; Huttenhower C; Sharma P; Watowich SS; Allison JP; Cohen L; Trinchieri G; Daniel CR; Wargo JA
    Science; 2021 Dec; 374(6575):1632-1640. PubMed ID: 34941392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Checkpoint Checkmate: Microbiota Modulation of Cancer Immunotherapy.
    Keen EC; Crofts TS; Dantas G
    Clin Chem; 2018 Sep; 64(9):1280-1283. PubMed ID: 29691222
    [No Abstract]   [Full Text] [Related]  

  • 33. Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition.
    Guardamagna M; Berciano-Guerrero MA; Villaescusa-González B; Perez-Ruiz E; Oliver J; Lavado-Valenzuela R; Rueda-Dominguez A; Barragán I; Queipo-Ortuño MI
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome.
    Warner AB; McQuade JL
    Curr Oncol Rep; 2019 Jul; 21(8):72. PubMed ID: 31263961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Microbiome and Liver Cancer.
    Myojin Y; Greten TF
    Cancer J; 2023 Mar-Apr 01; 29(2):57-60. PubMed ID: 36957974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spiking immunotherapy with a bacterial cocktail brings T cells back to the fight.
    Greathouse KL; Choudhury A
    Cell Rep Med; 2021 Oct; 2(10):100430. PubMed ID: 34755141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
    Routy B; Lenehan JG; Miller WH; Jamal R; Messaoudene M; Daisley BA; Hes C; Al KF; Martinez-Gili L; Punčochář M; Ernst S; Logan D; Belanger K; Esfahani K; Richard C; Ninkov M; Piccinno G; Armanini F; Pinto F; Krishnamoorthy M; Figueredo R; Thebault P; Takis P; Magrill J; Ramsay L; Derosa L; Marchesi JR; Parvathy SN; Elkrief A; Watson IR; Lapointe R; Segata N; Haeryfar SMM; Mullish BH; Silverman MS; Burton JP; Maleki Vareki S
    Nat Med; 2023 Aug; 29(8):2121-2132. PubMed ID: 37414899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
    Matson V; Fessler J; Bao R; Chongsuwat T; Zha Y; Alegre ML; Luke JJ; Gajewski TF
    Science; 2018 Jan; 359(6371):104-108. PubMed ID: 29302014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
    Davar D; Dzutsev AK; McCulloch JA; Rodrigues RR; Chauvin JM; Morrison RM; Deblasio RN; Menna C; Ding Q; Pagliano O; Zidi B; Zhang S; Badger JH; Vetizou M; Cole AM; Fernandes MR; Prescott S; Costa RGF; Balaji AK; Morgun A; Vujkovic-Cvijin I; Wang H; Borhani AA; Schwartz MB; Dubner HM; Ernst SJ; Rose A; Najjar YG; Belkaid Y; Kirkwood JM; Trinchieri G; Zarour HM
    Science; 2021 Feb; 371(6529):595-602. PubMed ID: 33542131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unbiased Microbiome and Metabolomic Profiling of Fecal Samples from Patients with Melanoma.
    Bui A; Choi Y; Frankel AE; Koh AY
    Methods Mol Biol; 2021; 2265():461-474. PubMed ID: 33704734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.